COMPANY
Solenic Medical, Inc.
Timeline
- Trial start Not phased (device or behavioral study): Sola2 AMF Knee System Added to Surgery and Antibiotics in Adults With Knee Implant Infection source ↗
Upcoming milestones
- 2028-08 (ESTIMATED) · Not phased · Sola2 AMF Knee System Added to Surgery and Antibiotics in Adults With Knee Implant Infection · NCT07700927
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07700927 | Sola2 AMF Knee System Added to Surgery and Antibiotics in Adults With Knee Implant Infection | Not phased (device or behavioral study) | Not yet recruiting | Sep 18, 2026 | 2028-08 (estimated) |
NIH awards 2
- NIH award 5R44AI155291-02 FY2021: $759,212 awarded for that fiscal year; activity R44 (SBIR); PI TEPPER, JOHN CHARLES; recipient as written: SOLENIC MEDICAL INC, COLLEGE STATION, TX. Noninvasive Treatment of Biofilm source ↗
- NIH award 1R44AI155291-01 FY2020: $583,358 awarded for that fiscal year; activity R44 (SBIR); PI TEPPER, JOHN CHARLES; recipient as written: SOLENIC MEDICAL INC, COLLEGE STATION, TX. Noninvasive Treatment of Biofilm source ↗